{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:19:15Z","timestamp":1792603155666,"version":"4.5.0"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Thrombotic disorders are among the leading causes of morbidity and\nmortality worldwide. Drugs used in the prevention and treatment of atherothrombosis have pharmacokinetic\nlimitations and adverse effects such as hemorrhagic conditions, highlighting the importance\nof developing more effective antiplatelet agents.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this work, we synthesized N,N'-disubstituted ureas 3a-3j and evaluated their antiplatelet\nprofiles through in vitro, ex vivo, and in silico studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The synthesized derivatives exhibited a selective inhibitory profile against platelet aggregation\ninduced by arachidonic acid (AA) in vitro, without significantly affecting other aspects of\nprimary hemostasis and blood coagulation. The compounds that showed inhibition greater than\n85% were submitted to the analysis of their potency by calculating the concentration required to inhibit\n50% of platelet aggregation induced by AA (IC50). Urea derivative 3a was the most potent\nwith IC50 of 1.45 \u03bcM. Interestingly, this derivative inhibited more than 90% of platelet aggregation\ninduced by AA ex vivo, with a similar effect to acetylsalicylic acid. In the hemolysis assay,\nmost of the urea derivatives presented values below 10% suggesting good hemocompatibility. Additionally,\nthe compounds tested at 100 \u03bcM also showed no cytotoxic effects in HepG2 and Vero\ncells. The in silico results suggested that compound 3a may bind to the key residue of COX-1 similar\nto AA and known COX-1 inhibitors, and the results are also in agreement with our SAR,\nwhich suggests that the inhibition of this enzyme is the most likely mechanism of antiplatelet activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Therefore, these results demonstrated that N,N'-disubstituted ureas are promising candidates\nfor the development of novel antiplatelet agents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673262854231215065541","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T10:10:36Z","timestamp":1707041436000},"page":"806-824","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["N,N'-disubstituted Ureas as Novel Antiplatelet Agents: Synthesis, Pharmacological Evaluation and In Silico Studies"],"prefix":"10.2174","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-5493","authenticated-orcid":true,"given":"Priscila","family":"de Souza Furtado","sequence":"first","affiliation":[{"name":"LABHEx, Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, lha do Fund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1742-8594","authenticated-orcid":true,"given":"Gil Mendes","family":"Viana","sequence":"additional","affiliation":[{"name":"LabTIF, Departamento de Farmacos e Medicamentos, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, Ilha do\nFund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-3254","authenticated-orcid":true,"given":"Alana Agnes Silva Camargo","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"LABHEx, Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, lha do Fund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5303-6814","authenticated-orcid":true,"given":"Vitor Won-Held","family":"Rabelo","sequence":"additional","affiliation":[{"name":"Instituto de Biodiversidade e Sustentabilidade NUPEM, Universidade Federal do Rio de Janeiro CEP 27965-045, Maca\u00e9, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingryd Wenderroschy","family":"Cerqueira","sequence":"additional","affiliation":[{"name":"Instituto de Biodiversidade e Sustentabilidade NUPEM, Universidade Federal do Rio de Janeiro CEP 27965-045, Maca\u00e9, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-4113","authenticated-orcid":true,"given":"Caroline Reis Santiago","family":"Paschoal","sequence":"additional","affiliation":[{"name":"LABHEx, Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, lha do Fund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"},{"name":"Instituto de Biodiversidade e Sustentabilidade NUPEM, Universidade Federal do Rio de Janeiro CEP 27965-045, Maca\u00e9, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3772-7225","authenticated-orcid":true,"given":"Thiago","family":"da Silva Honorio","sequence":"additional","affiliation":[{"name":"LabTIF, Departamento de Farmacos e Medicamentos, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, Ilha do\nFund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"},{"name":"Departamento de Farmacos e Medicamentos, Faculdade de Farm\u00e1cia, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro,\nLabCel, CEP 21941-902, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-6182","authenticated-orcid":true,"given":"Alice","family":"Simon","sequence":"additional","affiliation":[{"name":"LabTIF, Departamento de Farmacos e Medicamentos, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, Ilha do\nFund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"},{"name":"Departamento de Farmacos e Medicamentos, Faculdade de Farm\u00e1cia, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro,\nLabCel, CEP 21941-902, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-7654","authenticated-orcid":true,"given":"Carlos Rangel","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Departamento de Farmacos e Medicamentos, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, ModMolQSAR, Ilha do Fund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2204-3012","authenticated-orcid":true,"given":"Paula Alvarez","family":"Abreu","sequence":"additional","affiliation":[{"name":"Instituto de Biodiversidade e Sustentabilidade NUPEM, Universidade Federal do Rio de Janeiro CEP 27965-045, Maca\u00e9, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4550-5729","authenticated-orcid":true,"given":"Lucio Mendes","family":"Cabral","sequence":"additional","affiliation":[{"name":"LabTIF, Departamento de Farmacos e Medicamentos, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, Ilha do\nFund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"},{"name":"Departamento de Farmacos e Medicamentos, Faculdade de Farm\u00e1cia, Ilha do Fund\u00e3o, Universidade Federal do Rio de Janeiro,\nLabCel, CEP 21941-902, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1203-3179","authenticated-orcid":true,"given":"Pl\u00ednio Cunha","family":"Sathler","sequence":"additional","affiliation":[{"name":"LABHEx, Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro, lha do Fund\u00e3o, CEP 21941-902, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"12772","DOI":"10.3390\/ijms232112772","volume":"23","author":"Scridon A.","year":"2022","unstructured":"Scridon A.; Platelets and their role in hemostasis and thrombosis-from physiology to pathophysiology and therapeutic implications. Int J Mol Sci  2022,23(21),12772","journal-title":"Int J Mol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1187474","DOI":"10.3389\/fbioe.2023.1187474","volume":"11","author":"Cai D.","year":"2023","unstructured":"Cai D.; Weng W.; Development potential of extracellular matrix hydrogels as hemostatic materials. Front Bioeng Biotechnol  2023,11,1187474","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.3390\/molecules28135264","volume":"28","author":"Du J.","year":"2023","unstructured":"Du J.; Wang J.; Xu T.; Yao H.; Yu L.; Huang D.; Hemostasis strategies and recent advances in nanomaterials for hemostasis. Molecules  2023,28,5264","journal-title":"Molecules"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"10760296231205279","DOI":"10.1177\/10760296231205279","volume":"29","author":"Rodgers G.M.","year":"2023","unstructured":"Rodgers G.M.; Mahajerin A.; Antithrombin therapy: Current state and future outlook. Clin Appl Thromb Hemost  2023,29,10760296231205279","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.7861\/clinmedicine.18-4-320","volume":"18","author":"Gulati D.","year":"2018","unstructured":"Gulati D.; Novak A.; Stanworth S.J.; Common haemostasis issues in major bleeding and critical illness. Clin Med  2018,18(4),320-323","journal-title":"Clin Med"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1002\/9781118344729","author":"Key N.S.","year":"2017","unstructured":"Key N.S.; Makris M.; Lillicrap D.;  Practical Hemostasis and Thrombosis  2017","journal-title":"Practical Hemostasis and Thrombosis"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.3390\/ijms24076280","volume":"24","author":"Huseynov A.","year":"2023","unstructured":"Huseynov A.; Reinhardt J.; Chandra L.; D\u00fcrschmied D.; Langer H.F.; Novel aspects targeting platelets in atherosclerotic cardiovascular disease-a translational Perspective. Int J Mol Sci  2023,24,6280","journal-title":"Int J Mol Sci"},{"key":"ref=8","unstructured":"Cardiovascular diseases. WHO Available from:  https:\/\/www.who.int\/health-topics\/cardiovascular-diseases\/ (Accessed Sep 10, 2023)."},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/physrev.00016.2011","volume":"93","author":"Versteeg H.H.","year":"2013","unstructured":"Versteeg H.H.; Heemskerk J.W.M.; Levi M.; Reitsma P.H.; New fundamentals in hemostasis. Physiol Rev  2013,93(1),327-358","journal-title":"Physiol Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"Johnston S.C.","year":"2018","unstructured":"Johnston S.C.; Easton J.D.; Farrant M.; Barsan W.; Conwit R.A.; Elm J.J.; Kim A.S.; Lindblad A.S.; Palesch Y.Y.; Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med  2018,379(3),215-225","journal-title":"N Engl J Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","volume":"379","author":"McNeil J.J.","year":"2018","unstructured":"McNeil J.J.; Wolfe R.; Woods R.L.; Tonkin A.M.; Donnan G.A.; Nelson M.R.; Reid C.M.; Lockery J.E.; Kirpach B.; Storey E.; Shah R.C.; Williamson J.D.; Margolis K.L.; Ernst M.E.; Abhayaratna W.P.; Stocks N.; Fitzgerald S.M.; Orchard S.G.; Trevaks R.E.; Beilin L.J.; Johnston C.I.; Ryan J.; Radziszewska B.; Jelinek M.; Malik M.; Eaton C.B.; Brauer D.; Cloud G.; Wood E.M.; Mahady S.E.; Satterfield S.; Grimm R.; Murray A.M.; Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med  2018,379(16),1509-1518","journal-title":"N Engl J Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.14503\/THIJ-14-4986","volume":"43","author":"Pasala T.","year":"2016","unstructured":"Pasala T.; Hoo J.S.; Lockhart M.K.; Waheed R.; Sengodan P.; Alexander J.; Gandhi S.; Aspirin resistance predicts adverse cardiovascular events in patients with symptomatic peripheral artery disease. Tex Heart Inst J  2016,43(6),482-487","journal-title":"Tex Heart Inst J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.jvs.2017.07.065","volume":"66","author":"Guirgis M.","year":"2017","unstructured":"Guirgis M.; Thompson P.; Jansen S.; Review of aspirin and clopidogrel resistance in peripheral arterial disease. J Vasc Surg  2017,66(5),1576-1586","journal-title":"J Vasc Surg"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3109\/14756366.2016.1158712","volume":"31","author":"Saito M.S.","year":"2016","unstructured":"Saito M.S.; Louren\u00e7o A.L.; Dias L.R.S.; Freitas A.C.C.; Vitorino M.I.; Albuquerque M.G.; Rodrigues C.R.; Cabral L.M.; Dias E.P.; Castro H.C.; Satlher P.C.; Antiplatelet pyrazolopyridines derivatives: Pharmacological, biochemical and toxicological characterization. J Enzyme Inhib Med Chem  2016,31(6),1591-1601","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.3390\/molecules20047174","volume":"20","author":"Louren\u00e7o A.","year":"2015","unstructured":"Louren\u00e7o A.; Saito M.; Dorneles L.; viana G.; Sathler P.; Aguiar L.; de P\u00e1dula M.; Domingos T.; Fraga A.; Rodrigues C.; de Sousa V.; Castro H.; Cabral L.; Synthesis and antiplatelet activity of antithrombotic thiourea compounds: Biological and structure-activity relationship studies. Molecules  2015,20(4),7174-7200","journal-title":"Molecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"995351","DOI":"10.3389\/fchem.2022.995351","volume":"10","author":"Listro R.","year":"2022","unstructured":"Listro R.; Rossino G.; Piaggi F.; Sonekan F.F.; Rossi D.; Linciano P.; Collina S.; Urea-based anticancer agents. Exploring 100-years of research with an eye to the future. Front Chem  2022,10,995351","journal-title":"Front Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"131937","DOI":"10.1016\/j.molstruc.2021.131937","volume":"1251","author":"Cherukumalli P.K.R.","year":"2022","unstructured":"Cherukumalli P.K.R.; Tadiboina B.R.; Gulipalli K.C.; Bodige S.; Badavath V.N.; Sridhar G.; Gangarapu K.; Design and synthesis of novel urea derivatives of pyrimidine-pyrazoles as anticancer agents. J Mol Struct  2022,1251,131937","journal-title":"J Mol Struct"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4274\/tjps.64935","volume":"15","author":"Tok F.","year":"2018","unstructured":"Tok F.; \u0130lhan R.; G\u00fcnal S.; Ballar-k\u0131rm\u0131z\u0131bayrak P.; Ko\u00e7yi\u011fit-kaymak\u00e7\u0131o\u011flu B.; Design, synthesis and evaluation of biological activities of some new carbohydrazide and urea derivatives. Turk J Pharmaceut Sci  2018,15(3),304-308","journal-title":"Turk J Pharmaceut Sci"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/antibiotics8040178","volume":"8","author":"Patil M.","year":"2019","unstructured":"Patil M.; Noonikara-Poyil A.; Joshi S.D.; Patil S.A.; Patil S.A.; Bugarin A.; New urea derivatives as potential antimicrobial agents: Synthesis, biological evaluation, and molecular docking studies. Antibiotics  2019,8,178","journal-title":"Antibiotics"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"104104","DOI":"10.1016\/j.bioorg.2020.104104","volume":"102","author":"G\u00fcnd\u00fcz M.G.","year":"2020","unstructured":"G\u00fcnd\u00fcz M.G.; U\u011fur S.B.; G\u00fcney F.; \u00d6zkul C.; Krishna V.S.; Kaya S.; Sriram D.; Do\u011fan \u015e.D.; 1,3-Disubstituted urea derivatives: Synthesis, antimicrobial activity evaluation and in silico studies. Bioorg Chem  2020,102,104104","journal-title":"Bioorg Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1039\/C9MD00122K","volume":"10","author":"Vartak A.","year":"2019","unstructured":"Vartak A.; Goins C.; de Moura V.C.N.; Schreidah C.M.; Landgraf A.D.; Lin B.; Du J.; Jackson M.; Ronning D.R.; Sucheck S.J.; Biochemical and microbiological evaluation of N -aryl urea derivatives against mycobacteria and mycobacterial hydrolases. Med Chem Comm  2019,10(7),1197-1204","journal-title":"Med Chem Comm"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.apsb.2016.08.006","volume":"7","author":"Somakala K.","year":"2017","unstructured":"Somakala K.; Amir M.; Synthesis, characterization and pharmacological evaluation of pyrazolyl urea derivatives as potential anti-inflammatory agents. Acta Pharm Sin B  2017,7(2),230-240","journal-title":"Acta Pharm Sin B"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00044-016-1518-x","volume":"25","author":"Devineni S.R.","year":"2016","unstructured":"Devineni S.R.; Golla M.; Chamarthi N.R.; Meriga B.; Saddala M.S.; Asupathri U.R.; 2-Amino-2,3-dihydro-1H-2\u03bb5-[1,3,2]diazaphospholo[4,5-b]pyridin-2-one-based urea and thiourea derivatives: Synthesis, molecular docking study and evaluation of anti-inflammatory and antimicrobial activities. Med Chem Res  2016,25(4),751-768","journal-title":"Med Chem Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ejmech.2018.09.014","volume":"158","author":"Peng J.","year":"2018","unstructured":"Peng J.; Zhao L.; Wang L.; Chen H.; Qiu Y.; Wang J.; Yang H.; Liu J.; Liu H.; Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y receptor antagonists. Eur J Med Chem  2018,158,302-310","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/bkcs.11462","volume":"39","author":"Kim J.","year":"2018","unstructured":"Kim J.; Jung S.H.; Yun E.; Cho S.H.; Yuseok O.; Kim J.E.; Kim Y.H.; Myung C.S.; Song G.Y.; Synthesis of Novel 3- N -substituted carbazole derivatives and evaluation of their abilities to inhibit platelet aggregation. Bull Korean Chem Soc  2018,39(6),726-728","journal-title":"Bull Korean Chem Soc"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1055\/s-0036-1589149","volume":"50","author":"de Aguiar L.","year":"2018","unstructured":"de Aguiar L.; de Mattos M.; Sanabria C.; Costa B.; viana G.; Efficient direct halogenation of unsymmetrical N-benzyl- and N-phenylureas with trihaloisocyanuric acids. Synthesis  2018,50(6),1359-1367","journal-title":"Synthesis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1039\/C9QO01321K","volume":"7","author":"Ran X.","year":"2020","unstructured":"Ran X.; Long Y.; Yang S.; Peng C.; Zhang Y.; Qian S.; Jiang Z.; Zhang X.; Yang L.; Wang Z.; Yu X.; A novel route to unsymmetrical disubstituted ureas and thioureas by HMPA catalyzed reductive alkylation with trichlorosilane. Org Chem Front  2020,7(3),472-481","journal-title":"Org Chem Front"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1021\/acs.orglett.0c00510","volume":"22","author":"Malviya B.K.","year":"2020","unstructured":"Malviya B.K.; Jaiswal P.K.; Verma V.P.; Badsara S.S.; Sharma S.; Electrochemical synthesis of carbodiimides via metal\/oxidant-free oxidative cross-coupling of amines and isocyanides. Org Lett  2020,22(6),2323-2327","journal-title":"Org Lett"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1021\/acs.macromol.8b00321","volume":"51","author":"Pothupitiya J.U.","year":"2018","unstructured":"Pothupitiya J.U.; Hewawasam R.S.; Kiesewetter M.K.; Urea and thiourea h-bond donating catalysts for ring-opening polymerization: Mechanistic insights via (Non)linear free energy relationships. Macromolecules  2018,51(8),3203-3211","journal-title":"Macromolecules"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ajoc.201700598","volume":"7","author":"Guo J.Y.","year":"2018","unstructured":"Guo J.Y.; Zhong C.H.; He Z.Y.; Tian S.K.; Benzyne-Promoted curtius-type rearrangement of acyl hydrazides in the presence of nucleophiles. Asian J Org Chem  2018,7(1),119-122","journal-title":"Asian J Org Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1021\/jo500492x","volume":"79","author":"Spyropoulos C.","year":"2014","unstructured":"Spyropoulos C.; Kokotos C.G.; One-pot synthesis of ureas from Boc-protected amines. J Org Chem  2014,79(10),4477-4483","journal-title":"J Org Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"9337","DOI":"10.1039\/C8CC05462B","volume":"54","author":"Pawar G.G.","year":"2018","unstructured":"Pawar G.G.; Robert F.; Grau E.; Cramail H.; Landais Y.; Visible-light photocatalyzed oxidative decarboxylation of oxamic acids: A green route to urethanes and ureas. Chem Commun  2018,54(67),9337-9340","journal-title":"Chem Commun"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/md16090304","volume":"16","author":"Vasconcelos A.","year":"2018","unstructured":"Vasconcelos A.; Sucupira I.; Guedes A.; Queiroz I.; Frattani F.; Fonseca R.; Pomin V.; Anticoagulant and antithrombotic properties of three structurally correlated sea urchin sulfated glycans and their low-molecular-weight derivatives. Mar Drugs  2018,16(9),304","journal-title":"Mar Drugs"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.3390\/molecules24112156","volume":"24","author":"Cui J.","year":"2019","unstructured":"Cui J.; Hu L.A.; Shi W.; Cui G.; Zhang X.; Zhang Q.W.; Design, synthesis and anti-platelet aggregation activity study of ginkgolide-1,2,3-triazole derivatives. Molecules  2019,24(11),2156","journal-title":"Molecules"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.thromres.2014.05.009","volume":"134","author":"Sathler P.C.","year":"2014","unstructured":"Sathler P.C.; Louren\u00e7o A.L.; Rodrigues C.R.; da Silva L.C.R.P.; Cabral L.M.; Jord\u00e3o A.K.; Cunha A.C.; Vieira M.C.B.; Ferreira V.F.; Carvalho-Pinto C.E.; Kang H.C.; Castro H.C.; In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems. Thromb Res  2014,134(2),376-383","journal-title":"Thromb Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijbiomac.2004.12.002","volume":"35","author":"Martinichen-Herrero J.C.","year":"2005","unstructured":"Martinichen-Herrero J.C.; Carbonero E.R.; Sassaki G.L.; Gorin P.A.J.; Iacomini M.; Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen Cladonia ibitipocae. Int J Biol Macromol  2005,35(1-2),97-102","journal-title":"Int J Biol Macromol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1160\/TH16-09-0694","volume":"117","author":"Sucupira I.D.","year":"2017","unstructured":"Sucupira I.D.; Oliveira S.N.M.C.G.; Santos G.R.C.; Mour\u00e3o P.A.S.; Fonseca R.; Improved anticoagulant effect of fucosylated chondroitin sulfate orally administered as gastroresistant tablets. Thromb Haemost  2017,117(4),662-670","journal-title":"Thromb Haemost"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.; Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods  1983,65(1-2),55-63","journal-title":"J Immunol Methods"},{"key":"ref=39","year":"2010","unstructured":"Molinspiration. Molinspiration Cheminformatics Available from: http:\/\/www.molinspiration.com\/cgi-bin\/properties (Cited 2011 Mar 26). 2010"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"\u0160ali A.","year":"1993","unstructured":"\u0160ali A.; Blundell T.L.; Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol  1993,234(3),779-815","journal-title":"J Mol Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"6.1","DOI":"10.1002\/cpbi.3","volume":"54","author":"Webb B.","year":"2016","unstructured":"Webb B.; Sali A.; Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics  2016,54(1),6.1-, 37","journal-title":"Curr Protoc Bioinformatics"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","volume":"18","author":"Guex N.","year":"1997","unstructured":"Guex N.; Peitsch M.C.; SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis  1997,18(15),2714-2723","journal-title":"Electrophoresis"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"Laskowski R.A.","year":"1993","unstructured":"Laskowski R.A.; MacArthur M.W.; Moss D.S.; Thornton J.M.; PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst  1993,26(2),283-291","journal-title":"J Appl Cryst"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1126\/science.1853201","volume":"253","author":"Bowie J.U.","year":"1991","unstructured":"Bowie J.U.; L\u00fcthy R.; Eisenberg D.; A method to identify protein sequences that fold into a known three-dimensional structure. Science  1991,253(5016),164-170","journal-title":"Science"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/356083a0","volume":"356","author":"L\u00fcthy R.","year":"1992","unstructured":"L\u00fcthy R.; Bowie J.U.; Eisenberg D.; Assessment of protein models with three-dimensional profiles. Nature  1992,356(6364),83-85","journal-title":"Nature"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/prot.340170404","volume":"17","author":"Sippl M.J.","year":"1993","unstructured":"Sippl M.J.; Recognition of errors in three-dimensional structures of proteins. Proteins  1993,17(4),355-362","journal-title":"Proteins"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"Wiederstein M.","year":"2007","unstructured":"Wiederstein M.; Sippl M.J.; ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res  2007,35(Web Server),W407-W410","journal-title":"Nucleic Acids Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","volume":"53","author":"Koes D.R.","year":"2013","unstructured":"Koes D.R.; Baumgartner M.P.; Camacho C.J.; Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model  2013,53(8),1893-1904","journal-title":"J Chem Inf Model"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1254\/jjp.41.393","volume":"41","author":"Hiraku S.","year":"1986","unstructured":"Hiraku S.; Taniguchi K.; Wakitani K.; Omawari N.; KtRA H.; Miyamoto T.; Okegawa T.; Kawasaki A.; Ujiie A.; Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2- propenoic acid (OKY-046). Jpn J Pharmacol  1986,41(3),393-401","journal-title":"Jpn J Pharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/jop.2000.16.353","volume":"16","author":"Van Haeringen N.J.","year":"2000","unstructured":"Van Haeringen N.J.; Van Sorge A.A.; Cor\u00e9-Bodelier V.M.W.C.; Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen. J Ocul Pharmacol Ther  2000,16(4),353-361","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e0155183","DOI":"10.1371\/journal.pone.0155183","volume":"11","author":"Quiroga R.","year":"2016","unstructured":"Quiroga R.; Villarreal M.A.; Vinardo: A scoring function based on autodock vina improves scoring, docking, and virtual screening. PLoS One  2016,11(5),e0155183","journal-title":"PLoS One"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"Cheng F.","year":"2012","unstructured":"Cheng F.; Li W.; Zhou Y.; Shen J.; Wu Z.; Liu G.; Lee P.W.; Tang Y.; admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model  2012,52(11),3099-3105","journal-title":"J Chem Inf Model"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"Pires D.E.V.","year":"2015","unstructured":"Pires D.E.V.; Blundell T.L.; Ascher D.B.; pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem  2015,58(9),4066-4072","journal-title":"J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev  2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"Veber D.F.","year":"2002","unstructured":"Veber D.F.; Johnson S.R.; Cheng H.Y.; Smith B.R.; Ward K.W.; Kopple K.D.; Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem  2002,45(12),2615-2623","journal-title":"J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/jm701122q","volume":"51","author":"Gleeson M.P.","year":"2008","unstructured":"Gleeson M.P.; Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem  2008,51(4),817-834","journal-title":"J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","volume":"18","author":"Hughes J.D.","year":"2008","unstructured":"Hughes J.D.; Blagg J.; Price D.A.; Bailey S.; DeCrescenzo G.A.; Devraj R.V.; Ellsworth E.; Fobian Y.M.; Gibbs M.E.; Gilles R.W.; Greene N.; Huang E.; Krieger-Burke T.; Loesel J.; Wager T.; Whiteley L.; Zhang Y.; Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett  2008,18(17),4872-4875","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"9763","DOI":"10.1021\/jm301008n","volume":"55","author":"Bruns R.F.","year":"2012","unstructured":"Bruns R.F.; Watson I.A.; Rules for identifying potentially reactive or promiscuous compounds. J Med Chem  2012,55(22),9763-9772","journal-title":"J Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","volume":"33","author":"Lagorce D.","year":"2017","unstructured":"Lagorce D.; Bouslama L.; Becot J.; Miteva M.A.; Villoutreix B.O.; FAF-Drugs4: Free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics  2017,33(22),3658-3660","journal-title":"Bioinformatics"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-60327-235-3_5","author":"Kochar J.","year":"2010","unstructured":"Kochar J.; Gaziano J.M.; Aspirin in primary and secondary prevention of cardiovascular disease. Antithrombotic Drug Therapy in Cardiovascular Disease  2010,117-129","journal-title":"Antithrombotic Drug Therapy in Cardiovascular Disease"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1016\/j.bmcl.2012.03.059","volume":"22","author":"Sashidhara K.V.","year":"2012","unstructured":"Sashidhara K.V.; Palnati G.R.; Avula S.R.; Singh S.; Jain M.; Dikshit M.; Synthesis and evaluation of anti-thrombotic activity of benzocoumarin amide derivatives. Bioorg Med Chem Lett  2012,22(9),3115-3121","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","volume":"24","author":"Fischer D.","year":"2003","unstructured":"Fischer D.; Li Y.; Ahlemeyer B.; Krieglstein J.; Kissel T.; In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials  2003,24(7),1121-1131","journal-title":"Biomaterials"},{"key":"ref=63","first-page":"34","year":"2009","unstructured":"Biological Evaluation of Medical Devices-Part 5: In vitro Cytotoxicity Testing International Organization for Standardization (ISO) 2009,34","journal-title":"Biological Evaluation of Medical Devices-Part 5: In vitro Cytotoxicity Testing"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3109\/14756366.2013.817403","volume":"29","author":"Sathler P.C.","year":"2014","unstructured":"Sathler P.C.; Santana M.; Louren\u00e7o A.L.; Rodrigues C.R.; Abreu P.; Cabral L.M.; Castro H.C.; Human thromboxane synthase: Comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel. J Enzyme Inhib Med Chem  2014,29(4),527-531","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1021\/bi301400t","volume":"52","author":"Chao W.C.","year":"2013","unstructured":"Chao W.C.; Lu J.F.; Wang J.S.; Yang H.C.; Pan T.A.; Chou S.C.W.; Wang L.H.; Chou P.T.; Probing ligand binding to thromboxane synthase. Biochemistry  2013,52(6),1113-1121","journal-title":"Biochemistry"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1021\/jm00096a017","volume":"35","author":"Ohshima E.","year":"1992","unstructured":"Ohshima E.; Takami H.; Sato H.; Mohri S.; Obase H.; Miki I.; Ishii A.; Shirakura S.; Karasawa A.; Kubo K.; Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 2. J Med Chem  1992,35(18),3402-3413","journal-title":"J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/prot.20497","volume":"60","author":"Cole J.C.","year":"2005","unstructured":"Cole J.C.; Murray C.W.; Nissink J.W.M.; Taylor R.D.; Taylor R.; Comparing protein-ligand docking programs is difficult. Proteins  2005,60(3),325-332","journal-title":"Proteins"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1021\/jm0302997","volume":"47","author":"Kontoyianni M.","year":"2004","unstructured":"Kontoyianni M.; McClellan L.M.; Sokol G.S.; Evaluation of docking performance: Comparative data on docking algorithms. J Med Chem  2004,47(3),558-565","journal-title":"J Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1021\/jm060999m","volume":"49","author":"Leach A.R.","year":"2006","unstructured":"Leach A.R.; Shoichet B.K.; Peishoff C.E.; Prediction of protein-ligand interactions. Docking and scoring: Successes and gaps. J Med Chem  2006,49(20),5851-5855","journal-title":"J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1074\/jbc.271.4.2179","volume":"271","author":"Bhattacharyya D.K.","year":"1996","unstructured":"Bhattacharyya D.K.; Lecomte M.; Rieke C.J.; Garavito R.M.; Smith W.L.; Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1. J Biol Chem  1996,271(4),2179-2184","journal-title":"J Biol Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.2174\/138161207782794275","volume":"13","author":"Reddy R.","year":"2007","unstructured":"Reddy R.; Mutyala R.; Aparoy P.; Reddanna P.; Reddy M.; Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs. Curr Pharm Des  2007,13(34),3505-3517","journal-title":"Curr Pharm Des"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/jm0613166","volume":"50","author":"Blobaum A.L.","year":"2007","unstructured":"Blobaum A.L.; Marnett L.J.; Structural and functional basis of cyclooxygenase inhibition. J Med Chem  2007,50(7),1425-1441","journal-title":"J Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"28096","DOI":"10.1074\/jbc.M701335200","volume":"282","author":"Harman C.A.","year":"2007","unstructured":"Harman C.A.; Turman M.V.; Kozak K.R.; Marnett L.J.; Smith W.L.; Garavito R.M.; Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-\u03b1-substituted indomethacin ethanolamides. J Biol Chem  2007,282(38),28096-28105","journal-title":"J Biol Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/med.21389","volume":"36","author":"Vitale P.","year":"2016","unstructured":"Vitale P.; Panella A.; Scilimati A.; Perrone M.G.; COX-1 inhibitors: Beyond structure toward therapy. Med Res Rev  2016,36(4),641-671","journal-title":"Med Res Rev"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","volume":"44","author":"Siramshetty V.B.","year":"2016","unstructured":"Siramshetty V.B.; Nickel J.; Omieczynski C.; Gohlke B.O.; Drwal M.N.; Preissner R.; WITHDRAWN-a resource for withdrawn and discontinued drugs. Nucleic Acids Res  2016,44(D1),D1080-D1086","journal-title":"Nucleic Acids Res"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673262854231215065541","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/225775\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673262854231215065541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T12:59:25Z","timestamp":1739451565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/225775\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673262854231215065541","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}